AAPS 2016
Lab-on-a-chip diagnostics to enable affordable research
Researchers in sub-Saharan Africa have developed a plug-and-play lab-on-a-chip - a ‘nontraditional approach’ to a global problem, says AAPS plenary speaker.
AAPS 2016
Researchers in sub-Saharan Africa have developed a plug-and-play lab-on-a-chip - a ‘nontraditional approach’ to a global problem, says AAPS plenary speaker.
Industry efforts to comply with new US track and trace rules are accelerating, but concerns remain about the quality of symbols used to mark products according to GS1 US.
DISPATCHES FROM AAPS 2016
The flexibility of clinical development for products on designated accelerated pathways is leading to at-risk investments in commercial manufacturing, say Pfizer and the FDA.
Manufacturing quality is key for biosimilar success says Pfenex, as the US FDA continues to increase its regulatory oversight.